European life sciences investment major Sofinnova Partners is losing 40-year veteran and managing partner Monique Saulnier. The post Veteran Sofinnova Partners COO Saulnier to retire after 40 years with firm first appeared on AltAssets Private Equity
Life sciences investor Catalio Capital Management has boosted its 2022 fundraising with the final close of its inaugural special situations fund. The post Biomed investor Catalio Capital boosts 2022 fundraising with debut credit opportunities fund close
JP Morgan Asset Management has launched a new life sciences private equity team targeting early and growth stage healthcare companies. The post JP Morgan AM launches life sciences private equity team first appeared on AltAssets
London-based Apposite Capital has hit a £200m final close for its latest fund targeting high growth and high impact healthcare and life science SMEs across Europe. The post Powerful returns see healthcare investor Apposite Capital
Global sustainable infrastructure investor Actis has bought Rx Propellant, a platform focused on providing R&D labs and facilities to tenants in the life sciences and related sectors in India. The post Actis eyes Indian life
Global buyout giant Apollo has bought a minority stake in European life sciences investment major Sofinnova Partners, as well as agreeing to commit up to €1bn to its funds. The post Apollo buys into European
Life sciences investor Catalio Capital Management has soared past its target for its third flagship fundraise through a $381m final close. The post Catalio Capital Management flies past Fund III goal to reach $381m final close
Frazier Healthcare Partners has beaten its goal for its latest life sciences-focused fundraise by picking up $987m for a final close of the vehicle. The post Frazier Healthcare Partners soars past last life sciences fund
Nordic life science-focused venture capital house Eir Ventures has hit a €122.3m final close for its debut fundraise. The post Eir Ventures picks up over €122m of investing power focused on Nordic life science sector
Specialist venture capital house Mission BioCapital has raised $275m for its fifth flagship fundraise, more than double the amount it collected for its predecessor vehicle. The post Mission BioCapital more than doubles last fund total
Venture capital major New Enterprise Associates has brought in veteran life sciences investor Michele Park as a partner in its Menlo Park office. The post VC giant NEA brings in life sciences veteran Park as
Life sciences-focused venture capital house Vida Ventures has boosted its assets under management to more than $1.7bn in just four years through the final close of its oversubscribed third fund. The post Life science specialist
Advent Life Sciences, a transatlantic venture firm focused on life science companies, has closed a pair of new funds totalling $215m.
A team of former OrbiMed Advisors investment professionals have raised $410m for the final close of their debut Petrichor Healthcare Capital Management fund.
TVM Capital Life Science has held the $478m final close of its second Innovation fund, which will back life science companies in North America and Europe.
European life sciences venture capital major Sofinnova Partners has brought on board experienced former Abingworth investor Joe Anderson as a partner.
Life sciences-focused private equity house Aisling Capital has raised more than $144m towards its latest flagship fundraise.
Life sciences venture capital firm Sofinnova Partners has sold its portfolio company Corvidia Therapeutics to Novo Nordisk for $2.1bn.
